Supriya Lifescience Limited has informed the Exchange about Transcript
SUPRIYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Supriya Lifescience has informed the stock exchanges that the transcript of its earnings call held on August 14, 2025 — covering the unaudited financial results for the quarter ended June 30, 2025 (Q1FY26) — has been uploaded to the company's investor relations webpage. This is a routine disclosure compliance filing and does not itself contain any financial figures, guidance, or strategic commentary. Investors interested in management's actual remarks would need to read the full transcript on the company's website.
No direct impact on the stock or shareholders from this filing alone, as it is a procedural compliance update. The underlying earnings call transcript, however, may contain material commentary on margins, outlook, or pipeline that could influence sentiment if reviewed.